Longitude Capital Partners IV LLC 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:45 pm Purchase |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Longitude Capital Partners IV LLC | 2,765,381 8.400% |
198,281 (+7.72%) |
Filing |
| 2024-02-13 4:43 pm Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Longitude Capital Partners IV LLC | 2,567,100 9.600% |
2,567,100 (New Position) |
Filing |